Plus   Neg

La-Z Boy Q3 Profit Beats Street View, Shares Up 5%

Shares of La-Z-Boy Inc (LZB) gained nearly 5% in after hours trading on Tuesday after the company's third-quarter profit trumped Wall Street estimates.

Monroe, Michigan-based La-Z-Boy's third-quarter profit rose to $34.5 million or $0.74 per share from $28.7 million or $0.61 per share last year.

Excluding items, La-Z-Boy's adjusted earnings for the quarter were $0.72 per share. Analysts polled by Thomson Reuters estimate earnings of $0.63 per share for the quarter.

The company's revenue for the quarter rose 1.8% to $475.9 million from $467.6 million last year. Analysts had a consensus revenue estimate of $481.05 million.

Sales in the company's Upholstery segment increased 0.7% to $336.7 million, while Retail segment increased 5.1% to $167.5 million.

$36.18, down $0.31 or 0.85%, on the NYSE. The stock further dropped $2.98 or 8.24% in the after-hours trading.

LZB closed Tuesday's trading at $32.50, up $0.42 or 1.31%, on the NYSE. The stock further gained $1.50 or 4.62%, in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT